Intravenous Antiepileptic Drugs in Russia

Intravenous Antiepileptic Drugs in Russia

Launching four intravenous antiepileptic drugs: valproate (Depakene and Convulex), lacosamide (Vimpat), and levetiracetam (Keppra) – into the Russian market has significantly broadened the possibilities of rendering care to patients in seizure emergency situations. The chemi- cal structure, mechanis...

Full description

Bibliographic Details
Main Author: P. N. Vlasov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-07-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
intravenous antiepileptic drugs
aeds
sodium valproate
lacosamide
levetiracetam
status epilepticus
seizure clusters.
Online Access:https://nnp.ima-press.net/nnp/article/view/414
Description
Summary:Launching four intravenous antiepileptic drugs: valproate (Depakene and Convulex), lacosamide (Vimpat), and levetiracetam (Keppra) – into the Russian market has significantly broadened the possibilities of rendering care to patients in seizure emergency situations. The chemi- cal structure, mechanisms of action, indications/contraindications, clinical effectiveness and tolerability, advantages/disadvantages, and adverse events of using these drugs in urgent and elective neurology are discussed.
ISSN:2074-2711
2310-1342

Similar Items